Multipotent mesenchymal stem cells in lung fibrosis.

Area of Science:

• Pulmonary Medicine
• Stem Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) have been identified in human lung tissue, but their function in lung diseases remains unclear.
• This study aimed to isolate and characterize lung MSCs and investigate their in vitro properties.

Purpose of the Study:

• To isolate mesenchymal stem cells (MSCs) from human lung tissue.
• To characterize the in vitro properties of lung MSCs.
• To evaluate the effect of MSC-conditioned media on fibroblast proliferation and epithelial wound repair.

Main Methods:

• MSCs were cultured from lung tissue of patients with fibrotic lung disease, emphysema, and normal controls.
• Immunofluorescence staining was used for cell characterization and origin determination.
• The impact of MSC-conditioned media (MSC-CM) on lung fibroblast proliferation and epithelial repair was assessed in vitro.

Main Results:

• Lung MSCs were identified by CD44, CD90, CD105 expression and stained positive for pluripotency markers Oct3/4 and Nanog.
• MSC-CM significantly inhibited lung fibroblast proliferation by 29% and enhanced lung epithelial repair by 32%.
• Significantly higher numbers of MSCs were isolated from fibrotic lungs compared to emphysema or normal lungs.

Conclusions:

• Fibrotic lung tissue harbors increased numbers of MSCs compared to emphysema or normal lungs.
• Lung MSCs exhibit inhibitory effects on fibroblast proliferation and promote epithelial repair in vitro.
• Further in vivo research is warranted to explore the therapeutic potential of lung MSCs for treating lung fibrosis.